(Q35843658)

10 August 2017

1 reference

title

Demethylation of DNA by decitabine in cancer chemotherapy (English)

1 reference

10 August 2017

1 reference

Robert Brown

1

1 reference

10 August 2017

Jane A Plumb

series ordinal

2

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Expert Review of Anticancer Therapy

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

501-510

1 reference

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Zebularine: A Novel DNA Methylation Inhibitor that Forms a Covalent Complex with DNA Methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Methylation-induced repression--belts, braces, and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Genomic imprinting in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.4.501

21 January 2018

Identifiers

DOI

10.1586/14737140.4.4.501

1 reference

10 August 2017

1 reference